ClinicalTrials.Veeva

Menu

Mycotoxin Exposure and Dietary Habits in Colorectal Cancer Prevention and Development Among Polish Population

U

University of Warmia and Mazury in Olsztyn

Status

Unknown

Conditions

Colorectal Cancer, Somatic (Diagnosis)

Treatments

Procedure: colonoscopy
Other: anthropometric data collections
Other: questionnaires
Other: demographic data collections
Procedure: Collecte the biological samples

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is the determination of the zearalenone and its metabolites (α and β) level in the blood plasma and faeces of patients at increased risk of cancer, in relation to the nutrition data (FFQ) and information on the quality of life dependent on health (WHOQOL-BREF).

The study is performer within the framework of the Polish Colonoscopy Screening Program. Within the study 100 volunteers between 50 and 65 years of age. while, the colonoscopies will be performed in Provincial Specialist Hospital in Olsztyn. Patients with positive test result, who have been diagnosed with polyps or cancer, will be assigned to risk group. The study has been approved by a local bioethics committee.

Enrollment

100 estimated patients

Sex

All

Ages

50 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women aged from 50 to 65 years residing in Poland.

Exclusion criteria

  • subjects requiring long-term care due to somatic, mental retardation or other mental illness.
  • history of colorectal resection.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

No Intervention: Current screening practice.
Other group
Description:
Patients will be asked to complete the Food Frequency Questionnaire (FFQ) and the questionnaire about The World Health Organization Quality Of Life (WHOQOL-BREF), also and will be collected the demographic and anthropometric data
Treatment:
Other: demographic data collections
Other: questionnaires
Other: anthropometric data collections
Experimental: Sequential screening strategy
Experimental group
Description:
People aged between 50-65, will take part in the study. Patients, which will take in a screening colonoscopy, will be divided into two groups according to the result obtained. The first group, will be constitute the patients with a positive test result, while the second group (control) will be constitute the patients with the negative test result. In addition, from the Subjects the samples of blood and faeces will be collected.
Treatment:
Procedure: Collecte the biological samples
Procedure: colonoscopy

Trial contacts and locations

1

Loading...

Central trial contact

Tomasz Sawicki, PhD; Katarzyna Przybyłowicz, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems